These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7582302)

  • 1. The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide.
    Thusu KG; Morin FC; Russell JA; Steinhorn RH
    Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1605-10. PubMed ID: 7582302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-specific effect of guanosine 3',5'-cyclic monophosphate phosphodiesterase inhibition in isolated lamb lungs.
    Steinhorn RH; Gordon JB; Tod ML
    Crit Care Med; 2000 Feb; 28(2):490-5. PubMed ID: 10708189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective pulmonary vasodilation induced by aerosolized zaprinast.
    Ichinose F; Adrie C; Hurford WE; Bloch KD; Zapol WM
    Anesthesiology; 1998 Feb; 88(2):410-6. PubMed ID: 9477062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged pulmonary vasodilator action of inhaled nitric oxide by Zaprinast in awake lambs.
    Ichinose F; Adrie C; Hurford WE; Zapol WM
    J Appl Physiol (1985); 1995 Apr; 78(4):1288-95. PubMed ID: 7615435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose phosphodiesterase inhibition improves responsiveness to inhaled nitric oxide in isolated lungs from endotoxemic rats.
    Klein A; Zils U; Bopp C; Gries A; Martin E; Gust R
    J Surg Res; 2007 Apr; 138(2):224-30. PubMed ID: 17275845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postnatal maturation of phosphodiesterase 5 (PDE5) in piglet pulmonary arteries: activity, expression, effects of PDE5 inhibitors, and role of the nitric oxide/cyclic GMP pathway.
    Moreno L; Losada B; Cogolludo Al; Lodi F; Lugnier C; Villamor E; Moro M; Tamargo J; Pérez-Vizcaíno F
    Pediatr Res; 2004 Oct; 56(4):563-70. PubMed ID: 15295092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension.
    Weimann J; Ullrich R; Hromi J; Fujino Y; Clark MW; Bloch KD; Zapol WM
    Anesthesiology; 2000 Jun; 92(6):1702-12. PubMed ID: 10839922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cGMP-specific phosphodiesterase inhibitor E4021 dilates the pulmonary circulation.
    Dukarm RC; Russell JA; Morin FC; Perry BJ; Steinhorn RH
    Am J Respir Crit Care Med; 1999 Sep; 160(3):858-65. PubMed ID: 10471609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipyridamole, a cGMP phosphodiesterase inhibitor, causes pulmonary vasodilation in the ovine fetus.
    Ziegler JW; Ivy DD; Fox JJ; Kinsella JP; Clarke WR; Abman SH
    Am J Physiol; 1995 Aug; 269(2 Pt 2):H473-9. PubMed ID: 7653611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo interactions of nitrovasodilators and zaprinast, a cGMP-selective phosphodiesterase inhibitor.
    Merkel LA; Rivera LM; Perrone MH; Lappe RW
    Eur J Pharmacol; 1992 May; 216(1):29-35. PubMed ID: 1326438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intravenous Zaprinast and inhaled nitric oxide on pulmonary hemodynamics and gas exchange in an ovine model of acute respiratory distress syndrome.
    Adrie C; Holzmann A; Hirani WM; Zapol WM; Hurford WE
    Anesthesiology; 2000 Aug; 93(2):422-30. PubMed ID: 10910492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered endothelium-dependent relaxations in lambs with high pulmonary blood flow and pulmonary hypertension.
    Steinhorn RH; Russell JA; Lakshminrusimha S; Gugino SF; Black SM; Fineman JR
    Am J Physiol Heart Circ Physiol; 2001 Jan; 280(1):H311-7. PubMed ID: 11123246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cGMP hydrolysing phosphodiesterases 1 and 5 in cerebral artery dilatation.
    Kruuse C; Rybalkin SD; Khurana TS; Jansen-Olesen I; Olesen J; Edvinsson L
    Eur J Pharmacol; 2001 May; 420(1):55-65. PubMed ID: 11412839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary and systemic effects of the phosphodiesterase inhibitor dipyridamole in newborn lambs with persistent pulmonary hypertension.
    Dukarm RC; Morin FC; Russell JA; Steinhorn RH
    Pediatr Res; 1998 Dec; 44(6):831-7. PubMed ID: 9853914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E4021, a selective phosphodiesterase 5 inhibitor, potentiates the vasodilator effect of inhaled nitric oxide in isolated perfused rat lungs.
    Ohnishi M; Oka M; Muramatsu M; Sato K; Kira S; Fukuchi Y
    J Cardiovasc Pharmacol; 1999 Apr; 33(4):619-24. PubMed ID: 10218733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the fetal lamb.
    Jaillard S; Larrue B; Deruelle P; Delelis A; Rakza T; Butrous G; Storme L
    Ann Thorac Surg; 2006 Mar; 81(3):935-42. PubMed ID: 16488698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase isozyme inhibition and the potentiation by zaprinast of endothelium-derived relaxing factor and guanylate cyclase stimulating agents in vascular smooth muscle.
    Harris AL; Lemp BM; Bentley RG; Perrone MH; Hamel LT; Silver PJ
    J Pharmacol Exp Ther; 1989 May; 249(2):394-400. PubMed ID: 2566675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined therapy with zaprinast and inhaled nitric oxide abolishes hypoxic pulmonary hypertension.
    Nagamine J; Hill LL; Pearl RG
    Crit Care Med; 2000 Jul; 28(7):2420-4. PubMed ID: 10921573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous dipyridamole enhances the effects of inhaled nitric oxide and prevents rebound pulmonary hypertension in piglets.
    Foubert L; De Wolf D; Mareels K; Van Belleghem Y; Reyntjens K; Mortier E; Van Nooten G
    Pediatr Res; 2002 Nov; 52(5):730-6. PubMed ID: 12409521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of selective phosphodiesterase III and V inhibitors on adrenergic and non-adrenergic, non-cholinergic relaxation responses of guinea-pig pulmonary arteries.
    Tasatargil A; Sadan G; Ozdem SS
    Auton Autacoid Pharmacol; 2003 Apr; 23(2):117-24. PubMed ID: 14511071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.